Dose-response study of modulation of gene expression in peripheral blood mononuclear cells by atorvastatin
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 16 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Mar 2008 New trial record.